Company Filing History:
3 out of 470 
1 out of 1,736 
1 out of 182 
Years Active: 2012-2018
Title: Innovations and Contributions of Douglas Thamm
Introduction
Douglas Thamm is a notable inventor based in Fort Collins, Colorado. He has made significant contributions to the field of veterinary medicine, particularly in the diagnosis and treatment of canine lymphoma. With a total of four patents to his name, Thamm's work has advanced the understanding and management of this serious disease in dogs.
Latest Patents
Thamm's latest patents include "Immunosignature based diagnosis and characterization of canine lymphoma" and "Lanthanide nanoparticle conjugates and uses thereof." The first patent focuses on methods for diagnosing and characterizing lymphoma, utilizing patient antibodies bound to peptide microarrays. This innovative approach allows for the evaluation of the disease-free interval following treatment and includes subtyping of lymphoma based on immunosignature characteristics. The second patent involves lanthanide nanoparticle conjugates, which are directed towards targeting, treating, and imaging disease states in patients, showcasing Thamm's commitment to advancing medical technology.
Career Highlights
Throughout his career, Douglas Thamm has worked with esteemed institutions such as the Colorado State University Research Foundation and Arizona State University. His research has not only contributed to academic knowledge but has also had practical applications in veterinary medicine.
Collaborations
Thamm has collaborated with notable colleagues, including Randy Ringold and Renee Parker. These partnerships have further enriched his research and innovation efforts.
Conclusion
Douglas Thamm's work exemplifies the intersection of innovation and veterinary medicine. His patents and research contributions continue to impact the diagnosis and treatment of canine lymphoma, highlighting his role as a leading inventor in this field.